Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes.


Journal

Diabetes technology & therapeutics
ISSN: 1557-8593
Titre abrégé: Diabetes Technol Ther
Pays: United States
ID NLM: 100889084

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 9 7 2020
medline: 14 1 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

Diabetes is associated with mortality and severity of coronavirus disease (COVID-19). Protecting against infection in health care workers at high risk of COVID-19 is critical. This report investigates the usefulness and safety of remote continuous glucose monitoring (CGM) in a patient with diabetes and severe interstitial pneumonia caused by the coronavirus disease. The Dexcom G4 Platinum CGM system

Identifiants

pubmed: 32639844
doi: 10.1089/dia.2020.0237
doi:

Substances chimiques

Blood Glucose 0
Insulin 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-80

Auteurs

Emi Ushigome (E)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masahiro Yamazaki (M)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masahide Hamaguchi (M)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Takamasa Ito (T)

Departments of Infection Control and Clinical Laboratory and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Shin Matsubara (S)

Medical Education & General Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Yasuhiro Tsuchido (Y)

Departments of Infection Control and Clinical Laboratory and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Yu Kasamatsu (Y)

Departments of Infection Control and Clinical Laboratory and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masaki Nakanishi (M)

Departments of Infection Control and Clinical Laboratory and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Naohisa Fujita (N)

Departments of Infection Control and Clinical Laboratory and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Michiaki Fukui (M)

Department of Endocrinology and Metabolism, Graduate School of Medical Science, and Kyoto Prefectural University of Medicine, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH